Adient (ADNT): Letko, Brosseau & Associates Inc added to its stake +41K shares
Letko, Brosseau & Associates Inc added to its stake in Adient, per its Q1 2026 13F.
- 1.62M
- Shares reported · +41K vs prior quarter
- 0.53%
- Disclosed portfolio weight
- $32.7M
- Reported value
- Holdings as of
- Mar 31, 2026
- Filed
- May 12, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 10, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On March 10, 2026, the Human Capital and Compensation Committee of Adient’s Board of Directors approved a one-time restricted stock unit retention award for James Conklin, Adient’s Executive Vice President, Americas (the “Special RSU Award”), pursuant to Adient’s 2021 Omnibus Incentive Plan, based on the centrality of his role in fiscal year 2026 and his key contributions to date.”
- May 6, 2026Company filing · Form 8-K · ResultsReported its results
What came next
- Jun 4, 2026Insider · 2 peopleInsiders: 2 sales (~$515K)
- Jul 6, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 6, 2026, Mark Oswald, Executive Vice President and Chief Financial Officer of Adient plc (the “Company”), provided notice that he intends to leave his position with the Company no later than December 31, 2026.”
- Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 20, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- Sep 2, 2026InsiderDirector sold ~$151K of ADNT shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Adient
For Adient, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ADNT page.
How this filing works
Explore the data
Common questions
What does this filing report about Adient (ADNT) stock?
Letko, Brosseau & Associates Inc added to its stake in Adient, per its Q1 2026 13F. Now 1.62M shares, $32.7M reported value, 0.53% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2026. Filed: May 12, 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Adient recently?
For Adient, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ADNT page.
Does this mean ADNT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Adient
- SEC Form 4Sep 4, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
- SEC Form 4Jun 5, 2026
- SEC Form 4Jun 5, 2026
- SEC Form 13F-HRMay 15, 2026
Everything OQRO holds on this company is on its ADNT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
